NCT03355443

Brief Summary

The primary aim of this study is \- to explore the usefulness of re-examination and retroflexion on adenoma miss rate (AMR) in the proximal colon. Other aims include to explore the data below when re-examination or retroflexion is used.

  • Adenoma detection rate, ADR
  • Polyp miss rate, PMR
  • Polyp detection rate, PDR
  • Withdrawal time, WT

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2017

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 22, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 28, 2017

Completed
3 days until next milestone

Study Start

First participant enrolled

December 1, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

November 28, 2017

Status Verified

November 1, 2017

Enrollment Period

1 year

First QC Date

November 22, 2017

Last Update Submit

November 22, 2017

Conditions

Keywords

ColonoscopyLower Gastrointestinal TractRe-examinationRetroflexion

Outcome Measures

Primary Outcomes (1)

  • Adenoma miss rate in the proximal colon (AMR)

    AMR refers to the rate of adenoma missing, calculated as the proportion of adenomas which are missing in the first examination. AMR in the proximal colon is calculated with only the proximal colon concerned.

    At the end of the procedure, up to 1 hour

Secondary Outcomes (1)

  • Adenoma Detection Rate in the proximal colon (ADR)

    At the end of the procedure, up to 1 hour

Study Arms (2)

Re-examination Group

ACTIVE COMPARATOR

Routine intubation is performed. After cecal intubation, the cecum and ascending colon is examined with colonoscope tip in forward direction for the first time. Re-intubation is performed after the first examination of the cecum and ascending colon, and then this region of the large bowel is re-examined in the same fashion. After that, the rest of the colon is examined in routine method.

Procedure: Re-examination

Retroflexion Group

EXPERIMENTAL

Routine intubation is performed. After cecal intubation, the cecum and ascending colon is examined with colonoscope tip in forward direction for the first time. Re-intubation is performed after the first examination of the cecum and ascending colon, and then this region of the large bowel is re-examined with the colonoscope tip in reverse direction (retroflexion fashion). After that, the rest of the colon is examined in routine method.

Procedure: Retroflexion

Interventions

RetroflexionPROCEDURE

Retroflexion technique in colonoscopy means turning the colonoscope tip 180 degree in order to look backward in the colon and rectum.

Retroflexion Group

Re-examination in colonoscopy means examining the cecum and ascending colon twice in the routine fashion.

Re-examination Group

Eligibility Criteria

Age45 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients between 45 and 80 years who undergo colonoscopy examination for screening, and who receive primary screening and get positive result

You may not qualify if:

  • Pregnant female patients
  • Patients received colonoscopy in the past 5 years
  • Patients who have history of colorectal cancer, colorectal polyposis, inflammatory bowel disease or heredity colorectal neoplasm syndrome such as familiar adenomatous polyposis, Lynch Syndrome and so on
  • Patients who had previous abdominal surgery
  • Patients who are known to have colonic stricture or obstructing tumor from the results of radiography (X ray, CT scan or barium enema)
  • Patients who are presenting acute surgical conditions such as severe colitis, megacolon and active gastrointestinal bleeding
  • Patients who have inadequate bowel preparation
  • Patients who reject to participate in this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

the Sixth affiliated Hospital of Sun Yat-Sen University

Guangzhou, Guangdong, 510655, China

Location

Zhongshan Hospital affiliated to Fudan University

Shanghai, 200032, China

Location

Tianjin Renmin Hospital

Tianjin, 300121, China

Location

Related Publications (4)

  • Kushnir VM, Oh YS, Hollander T, Chen CH, Sayuk GS, Davidson N, Mullady D, Murad FM, Sharabash NM, Ruettgers E, Dassopoulos T, Easler JJ, Gyawali CP, Edmundowicz SA, Early DS. Impact of retroflexion vs. second forward view examination of the right colon on adenoma detection: a comparison study. Am J Gastroenterol. 2015 Mar;110(3):415-22. doi: 10.1038/ajg.2015.21. Epub 2015 Mar 3.

  • Lee HS, Jeon SW, Park HY, Yeo SJ. Improved detection of right colon adenomas with additional retroflexion following two forward-view examinations: a prospective study. Endoscopy. 2017 Apr;49(4):334-341. doi: 10.1055/s-0042-119401. Epub 2016 Dec 8.

  • Hewett DG, Rex DK. Miss rate of right-sided colon examination during colonoscopy defined by retroflexion: an observational study. Gastrointest Endosc. 2011 Aug;74(2):246-52. doi: 10.1016/j.gie.2011.04.005. Epub 2011 Jun 15.

  • Wang CL, Zhao ZY, Wu JY, Yan FH, Yuan J, Xing JJ, Wang H, Yu ED. Efficacy of cecal retroflexion observed on adenoma missing of ascending colon during colonoscopy: A prospective, randomized, pilot trial. Medicine (Baltimore). 2023 Aug 25;102(34):e34806. doi: 10.1097/MD.0000000000034806.

Central Study Contacts

En-Da YU, MBBS

CONTACT

Zi-Ye ZHAO, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Department of Colorectal Surgery and Vice Director of GI Endoscopy

Study Record Dates

First Submitted

November 22, 2017

First Posted

November 28, 2017

Study Start

December 1, 2017

Primary Completion

December 1, 2018

Study Completion

December 1, 2019

Last Updated

November 28, 2017

Record last verified: 2017-11

Locations